Drugs used to treat leukemia can also be used to prevent melanoma metastasis, according to a new study by scientists at University of Kentucky Markey Cancer Center.
The study published in Science Signaling showed new evidence linking the activation of ABL kinases - cancer-promoting genes - to the secretion of pro-metastatic cathepsins in melanoma. Cathepsins are enzymes that degrade proteins and are highly expressed in cancer cells, resulting in their release into the environment between the cells. These enzymes "chew up" the fibrous matrix around tumors, which allows them to get into the blood stream and lymphatic system and spread around the body.
Advertisement
‘Repurposing leukemia drugs can treat metastatic melanoma patients.’
Tweet it Now
Their work showed that ABL kinases induce cathepsin expression and secretion by increasing the activity of key transcription factors that upregulate numerous proteins involved in metastasis. Transcription factors bind to the regulatory part of genes and induce their expression. This study is the first to demonstrate that ABL kinases not only increase the abundance of the transcription factors, but also regulate the ability of these transcription factors to bind to the promoters and induce gene expression.
Lastly, the scientists found that ABL kinases inhibitors already approved by the Food & Drug Administration (FDA) for treating leukemia also prevented metastasis induced by secreted cathepsins in animal models of metastatic melanoma.
![New Cancer-Causing Pathway Identified That Causes Leukemia]( "New Cancer-Causing Pathway Identified That Causes Leukemia")
The DNA of immature blood cells, mainly white cells, becomes damaged in some way. This abnormality causes the blood cells to grow and divide continuously.
"These data have important therapeutic implications, as drugs that inhibit ABL kinases have been used for decades to treat leukemia with few side effects," said Rakshamani Tripathi, postdoctoral scholar in the UK Department of Pharmacology and Nutritional Sciences and lead author on the study. "Repurposing these drugs may represent a new strategy for targeting cathepsins and may be an effective approach for treating metastatic melanoma patients."
The number of new cases of melanoma, as well as melanoma death rates, have increased steadily for the past 30 years in the United States. Metastasis to distant organ sites such as the lung, liver, brain and bone is the major cause of melanoma-related deaths. Despite new advances in metastatic melanoma treatment, the 5-year survival rate is only 15 to 20 percent.
Source: Eurekalert
New Cancer-Causing Pathway Identified That Causes Leukemia
The DNA of immature blood cells, mainly white cells, becomes damaged in some way. This abnormality causes the blood cells to grow and divide continuously.
Advertisement
"These data have important therapeutic implications, as drugs that inhibit ABL kinases have been used for decades to treat leukemia with few side effects," said Rakshamani Tripathi, postdoctoral scholar in the UK Department of Pharmacology and Nutritional Sciences and lead author on the study. "Repurposing these drugs may represent a new strategy for targeting cathepsins and may be an effective approach for treating metastatic melanoma patients."
The number of new cases of melanoma, as well as melanoma death rates, have increased steadily for the past 30 years in the United States. Metastasis to distant organ sites such as the lung, liver, brain and bone is the major cause of melanoma-related deaths. Despite new advances in metastatic melanoma treatment, the 5-year survival rate is only 15 to 20 percent.
Source: Eurekalert
Possibility Of Halting Melanoma Metastasis With The Help Of Research Breakthrough
Scientists have eliminated metastasis,in melanoma by inhibiting a protein known as melanoma differentiation associated gene-9 (mda-9)/syntenin in laboratory experiments.
Advertisement
 Protein Key to Melanoma Metastasis IdentifiedP-Rex1 - key protein behind metastasis of melanoma has been identified by UNC Lineberger Comprehensive Cancer Center researchers. | Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The blood test pinpointed 13 proteins capable of distinguishing between early and late stages of pancreatic cancer.
A fatty acid present in dairy products, beef, and lamb called trans-vaccenic acid enhances immune cells' capacity to combat cancers.
Trametinib plus dabrafenib combined therapy demonstrated a clear therapeutic benefit in children with BRAF-mutated low- and high-grade gliomas.
Examining breast cancer occurrence and stages reveals disparities in urban versus rural rates, influenced by environmental conditions and the stage of the disease.
Polymerases theta and delta assist in the development of new cancer drugs known as polymerase theta inhibitors, currently undergoing clinical trials.